>>> US After Hours Summary: CLGX +6%, TXN +6%, CR +5%, LVS +4.4% on e


After Hours Summary: CLGX +6%, TXN +6%, CR +5%, LVS +4.4% on earnings/guidance, semi and casino names higher in sympathy... SANM -10.8%, NDLS -6.9%, GILD -4% on earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: CRY +8.2% (ticking higher), CLGX +6.3%, TXN +5.8%, CR +5.3%, LVS +4.4%, CNXC +2.5% (thinly traded, also elects not to pay a distribution to holders of subordinated units for Q2), RE +0.9% (ticking higher), CNI +0.8%

Companies trading higher in after hours in reaction to news: SGY +9.6% (announces estimated production for the quarter ended June 30, 2016 of ~29 MBoe per day, slightly above the upper end of guidance for the quarter), ANCB +6% (Anchor Bancorp engages investment banking firm to assist it in identifying and evaluating various strategic options and operating scenarios), RAVN +4.1% and BEAT +3.8% (to join S&P SmallCap 600), MPEL +2.9%, WYNN +2.2%, MGM +1% (following LVS earnings), MBFI +1.2% (to join S&P MidCap 400), P +1.1% (following late surge higher -- reports that the company hired advisor for strategic options), SWHC +0.7% (Smith & Wesson to acquire Crimson Trace for $95.0 mln, subject to certain adjustments, utilizing cash on hand; expects the acquisition to be accretive to its EPS in fiscal 2017)

Select semi names are trading higher following TXN earnings: MXIM +4.9% , ADI +1.9%, NXPI +1.8%, LLTC +0.7%, MCHP +0.2%

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: SANM -10.8%, NDLS -6.9% (announces management and Board changes, sees Q2 revs below consensus), EFII -4.4% (light volume), GILD -4%, MPWR -3.6%, GIG -3.3%, CE -2.9%, CDNS -1.6%, SPN -1.6% (light volume), CMP -1.5%, VNOM -0.5% (thinly traded -  also announces a 7 mln common unit underwritten public offering)

Companies trading lower in after hours in reaction to newsMSTX -21.4% (Mast Therapeutics provides guidance on the anticipated timing for announcement of top-line data from the EPIC study, provided guidance on the anticipated timing for announcement of top-line data from the EPIC study), CRME -18.3% (announces proposed underwritten public offering of common stock), KLDX -5% (to acquire the Hollister mine and the Esmeralda mine and ore milling complex located in Northern Nevada; discloses CAD $100 mln bought deal financing), TCAP -3.8% (commences 6.25 mln common stock offering), PRKR -3.3% (files for ~1.44 mln share common stock offering by selling shareholders), CELG -3% (announces the Lymphoma Academic Research Organisation reported initial data from a phase III REMARC clinical study; REMARC achieved the primary endpoint of a statistically significant improvement inPFS for patients receiving REVLIMID)